• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov5
Cumberland Pharma released FY2025 Q3 earnings on November 4 After-Market EST, actual revenue USD 8.292 M, actual EPS USD -0.1299
00:00
Cumberland Pharma released FY2025 9 Months Earnings on November 4 After-Market EST, with actual revenue of USD 30.84 M and EPS of USD -0.0999
00:00
Oct28
Cumberland Pharma to Release FY2025 Q3 Earnings on November 4 After-Market EST
00:05
Oct1
Cumberland Pharmaceuticals' Injectable Ibuprofen Product Approved by Mexican Regulatory Authority
13:06
Sep29
Tabuk Pharmaceutical Launches Vibativ Antibiotic in Saudi Arabia
13:06
Aug5
Cumberland Pharma released FY2025 Semi-Annual earnings on August 5 After-Market (EST), actual revenue USD 22.55 M, actual EPS USD 0.0338
23:00

Schedules & Filings

Schedules
Filings
Nov4
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 8.292 M, Net Income -1.941 M, EPS -0.1299

Aug5
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 10.84 M, Net Income -740.74 K, EPS -0.05

May6
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 11.71 M, Net Income 1.257 M, EPS 0.08

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More